Out-of-Pocket Prescription Drug Expenses Are Manageable
Share it
As the cost of healthcare increases, the cost to payors and patients has increased as well. This should not be a surprise to anyone. This article however blatantly misrepresents the facts.
Yes, more people are on HDPs. However, the article never mentions the increase of HSA and HRA programs to offset this cost.
Pharma is offsetting a large portion of these increases with copay assistance and patient assistance. Raising the copay is no longer a slam dunk to move patients to a preferred alternative.
The measurements of the percent of drugs covered is based on the number of drugs available – not on the number of drugs prescribed. Around 85% of all medications used are generics, which are seldom impacted by PBM UM programs. The authors are not using a weighted average. The 18% basis point drop is nothing more than an attempt to overstate the issue.
Finally, the article is based on a paper from GoodRx. GoodRx generates revenue when patients seek access to a medication that is restricted or not covered by their plan as opposed to using the preferred therapy. Raising concern over out-of-pocket (OOP) prescription drug expenses increases use of their product.
Rx therapy is effective and affordable. If your members are struggling with OOP prescription drug expenses, then your PBM is not doing its job. Araya has many clients that are holding down both costs and member contribution. Contact us if you want to learn more.
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have
Shopping Basket
More Information?
Fill out your details and we will get back to you as soon as possible.
Out-of-Pocket Prescription Drug Expenses Are Manageable
As the cost of healthcare increases, the cost to payors and patients has increased as well. This should not be a surprise to anyone. This article however blatantly misrepresents the facts.
Finally, the article is based on a paper from GoodRx. GoodRx generates revenue when patients seek access to a medication that is restricted or not covered by their plan as opposed to using the preferred therapy. Raising concern over out-of-pocket (OOP) prescription drug expenses increases use of their product.
Rx therapy is effective and affordable. If your members are struggling with OOP prescription drug expenses, then your PBM is not doing its job. Araya has many clients that are holding down both costs and member contribution. Contact us if you want to learn more.
See more news
Government Solution Not Needed to Reduce Drug Costs
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
Transparent Pharmacy Benefits Are Possible
In a recent article at BenefitsPRO, Dan Cook talks about the movement to have employers “rise up and fight their own battles with the drug
The Real Issues With Prescription Drug Costs
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have